The Effect of IBD Flares on Serum PSA

Launched by NORTHWESTERN UNIVERSITY · Jun 5, 2018

Keywords

ClinConnect Summary

This clinical trial is studying how flares of Inflammatory Bowel Disease (IBD) affect the levels of a substance called Prostate Specific Antigen (PSA) in men. High PSA levels can sometimes indicate prostate cancer, so understanding how IBD flares influence these levels is important. The researchers will measure PSA levels in men with IBD before, during, and after a flare and look at how these changes relate to where the disease is located in the body. The goal is to improve prostate cancer screening for men with IBD, potentially reducing unnecessary tests and healthcare visits.

To participate in this study, men aged 40 to 69 with a confirmed diagnosis of IBD who visit the Northwestern Memorial Hospital Gastroenterology Clinic may be eligible. However, those with a history of prostate cancer or previous prostate procedures will not be able to take part. Participants can expect to provide blood samples for testing at different times related to their IBD flares, and the findings could lead to better screening practices for prostate cancer in men with IBD.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Men, ages 40-69 years old
• • Confirmed diagnosis of IBD presenting to the Northwestern Memorial Hospital Gastroenterology Clinic
• Exclusion Criteria:
• • History of prostate cancer or prior prostate procedures (biopsies or transurethral resection)